Treatment for the negative symptoms of schizophrenia
We need more daily victories over schizophrenia
If you or someone you care about is being treated for schizophrenia, learn about this research study of an investigational drug that is taken with current medication. To qualify for this study you or someone you know must:
- Be 18 to 55 years of age
- Have been diagnosed with schizophrenia for at least 1 year
- Be currently treated with an antipsychotic for at least 8 weeks prior to joining the study
- Have a caregiver or identified responsible person to provide support
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related time and travel may be provided.
Male or Female
Why take part?
Participants will receive study-related doctor’s care, study medication at no cost. Compensation for study-related time and travel may be available.
Millions of people lack the treatment they need to manage their conditions. As one of the largest and most recognized clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself.
Who is Synexus?
Synexus is a company dedicated to conducting clinical studies, and has been investigating the effectiveness of new study drugs and treatments for more than 20 years. We provide a friendly, relaxed environment in our own clinics where you have the chance to help shape the future of health for yourself and for others.
We are sure you probably have more questions about the study, and we would be happy to take the time to give you more details.
All Synexus studies are approved by an independent ethics committee.